Slimmer AI

Slimmer AI is a venture studio and investor based in the Netherlands, building and backing applied AI companies across selected verticals including B2B software, scientific publishing, and selectively healthcare-relevant categories. The structure is closer to a venture studio model than a classical fund, meaning capital is paired with operating, technical, and product support during early company building. Stage focus is pre-seed and seed, with checks typically in the EUR 250k to 1M range and the capacity to participate as a co-builder in studio-led projects. Healthcare exposure is opportunistic and most credible when a founder is building applied AI for clinical or operational workflows, scientific or life-sciences software, or B2B health AI with defensible technical depth. Physician founders building applied AI software with strong scientific or clinical anchoring, particularly those with European technical centers of gravity, are the right profile. Founders building therapeutics, devices, consumer wellness brands, or US-only commercial models without European nexus should pitch elsewhere. Geographic posture is European with a Dutch anchor. The realistic entry path is engagement with the studio’s published process or a warm introduction from a Dutch AI ecosystem operator. Treat Slimmer AI as a hybrid studio-and-investor partner that brings technical fluency, product support, and category insight rather than a traditional financial-only check.